Moreover, NCOA2 gene fusions have been identified in multiple cancer types, including spindle cell sarcomas [32], leukemia [33], rhabdomyosarcoma [34], and uterine sarcoma [35]. The gene discussed is NCOA2; the disease is uterine corpus sarcoma.